Literature DB >> 22214970

Utility of small biopsies for diagnosis of lung nodules: doing more with less.

Sanjay Mukhopadhyay1.   

Abstract

Small biopsies obtained by core needle or bronchoscopy are commonly used for diagnosis of lung nodules. This review provides guidance in two key areas of interpretation of small lung biopsies. The first part answers common questions regarding the immunohistochemical subclassification of non-small cell lung carcinomas that cannot be classified by standard criteria on hematoxylin-eosin-stained sections of small lung biopsies. The second part discusses common benign entities that can be diagnosed in core needle biopsies of lung nodules, such as granulomatous inflammation, parenchymal scars and organizing pneumonia. The approach to cases in which malignant cells are absent and features of a specific benign diagnosis are lacking is also addressed.

Entities:  

Mesh:

Year:  2012        PMID: 22214970     DOI: 10.1038/modpathol.2011.153

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

Review 1.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens.

Authors:  Diana Montezuma; Rosa Azevedo; Paula Lopes; Renata Vieira; Ana Luísa Cunha; Rui Henrique
Journal:  Virchows Arch       Date:  2013-10-15       Impact factor: 4.064

3.  Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC.

Authors:  F Xie; P Li; J Gong; H Tan; J Ma
Journal:  Clin Transl Oncol       Date:  2017-09-27       Impact factor: 3.405

Review 4.  Approaches to Evaluate Lung Inflammation in Translational Research.

Authors:  David K Meyerholz; Jessica C Sieren; Amanda P Beck; Heather A Flaherty
Journal:  Vet Pathol       Date:  2017-08-16       Impact factor: 2.221

5.  KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.

Authors:  Alyssa M Krasinskas; Simon I Chiosea; Timothy Pal; Sanja Dacic
Journal:  Mod Pathol       Date:  2013-07-26       Impact factor: 7.842

Review 6.  The state of the art for artificial intelligence in lung digital pathology.

Authors:  Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Pathol       Date:  2022-06-20       Impact factor: 9.883

7.  A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.

Authors:  Jon H Chung; Siraj M Ali; Jenni Davis; Karl Robstad; Richard McNally; Laurie M Gay; Rachel L Erlich; Norma A Palma; Phil J Stephens; Vincent A Miller; Alfonso Cutugno; Jeffrey S Ross
Journal:  Case Rep Oncol       Date:  2014-09-09

8.  Lobar location of lesions in computed tomography-guided lung biopsy is correlated with major pneumothorax: A STROBE-compliant retrospective study with 1452 cases.

Authors:  Weipeng Yan; Xiaofang Guo; Jing Zhang; Junfen Zhou; Changchun Chen; Manxiang Wang; Zhaoxi Zhang; Yulin Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

9.  PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.

Authors:  Wei Guo; Bing Hao; Hao-Jun Chen; Long Zhao; Zuo-Ming Luo; Hua Wu; Long Sun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-22       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.